PAPER
Aminobenzylphosphonium Salts – A Fluorescent Probe for Imaging of Biological Membranes
1543
H2O, and drying (Na2SO4), the solvent was evaporated. The residue
was finally purified by recrystallization from EtOH.
{[4-[Ethyl(2-hydroxyethyl)amino]phenyl]methyl}triphenyl-
phosphonium Iodide (6)
Mp 165–170 °C.
{[4-(Dibutylamino)phenyl]methyl}triphenylphosphonium
Iodide (2)
Mp 206–209 °C.
1H NMR (CDCl3): = 7.78 and 7.61 (m, 15 H), 6.75 (dd, J = 8.9,
2.4, 2 H), 6.46 (d, J = 8.7, 2 H), 4.78 (d, J = 12.8, 2 H), 3.68 (m, 2
H), 3.38 (m, 2 H), 3.31 (t, J = 7.0, 2 H), 2.61 (m, 1 H), 1.04 (t,
J = 7.0, 3 H).
13C NMR (CDCl3): = 147.3 (d, J = 2.6), 134.4 (d, J = 2.3), 133.3
(d, J = 9.6), 131.8 (d, J = 5.1), 129.5 (d, J = 12.3), 115.3 (d,
J = 85.0), 111.4, 110.3 (d, J = 8.7), 58.1, 51.4, 44.4, 29.8 (d,
J = 46.3), 11.2.
1H NMR (CDCl3): = 7.80 and 7.68 (m, 15 H), 6.82 (dd, J = 8.5,
1.8, 2 H), 6.37 (d, J = 8.5, 2 H), 4.93 (d, J = 12.7, 2 H), 3.18 (t,
J = 7.3, 4 H), 1.48 (m, 4 H), 1.28 (m, 4 H), 0.93 (t, J = 7.1, 6 H).
13C NMR (CDCl3): = 148.0 (d, J = 1.9), 134.9 (d, J = 2.8), 134.2
(d, J = 9.6), 132.0 (d, J = 4.9), 130.0 (d, J = 12.3), 117.7 (d,
J = 84.8), 111.5, 110.6 (d, J = 7.9), 50.4, 30.5 (d, J = 46.7), 29.0,
20.4, 13.5.
HRMS: m/z calcd for C29H31NOP (M+·): 440.2143, found:
440.2138.
31P NMR (CDCl3): = 20.9.
({4-[Bis(2-hydroxyethyl)amino]phenyl}methyl)triphenylphos-
phonium Iodide (7a)
Mp 175–180 °C.
Anal. Calcd for C33H39INP (607.56): C, 65.24; H, 6.47; I, 20.89; N,
2.31; P, 5.10. Found: C, 65.01; H, 6.62; I, 20.73; N, 2.32; P, 5.28.
{[4-(Dihexylamino)phenyl]methyl}triphenylphosphonium
Iodide (3)
Mp 147–148 °C.
1H NMR (DMSO-d6): = 7.90 and 7.69 (m, 15 H), 6.71 (dd,
J = 8.6, 1.9, 2 H), 6.50 (d, J = 8.8, 2 H), 4.97 (d, J = 14.5, 2 H), 4.70
(t, J = 5.2, 2 H), 3.45 (t, J = 5.1, 4 H), 3.34 (m, 4 H).
1H NMR (CDCl3): = 7.80 and 7.66 (m, 15 H), 6.80 (dd, J = 8.5,
2.1, 2 H), 6.37 (d, J = 8.5, 2 H), 4.85 (d, J = 12.7, 2 H), 3.17 (t,
J = 7.3, 4 H), 1.50 (m, 4 H), 1.29 (m, 12 H), 0.89 (t, J = 7.1, 6 H).
13C NMR (DMSO-d6): = 147.5 (d, J = 2.6), 134.7 (d, J = 2.5),
133.8 (d, J = 9.7), 131.3 (d, J = 5.2), 129.6 (d, J = 12.3), 118.0 (d,
J = 84.7), 111.9 (d, J = 8.8), 111.0, 57.7, 52.8, 27.4 (d, J = 45.8).
13C NMR (CDCl3): = 148.0 (d, J = 2.5), 134.9 (d, J = 2.9), 134.2
(d, J = 9.5), 132.0 (d, J = 5.1), 130.0 (d, J = 12.3), 117.7 (d,
J = 85.0), 111.6, 110.6 (d, J = 8.7), 50.7, 31.5, 30.6 (d, J = 46.3),
26.9, 26.6, 22.5, 13.9.
31P NMR (DMSO-d6): = 22.14.
HRMS: m/z calcd for C29H31NO2P (M+·): 456.2092, found:
456.2084.
31P NMR: (CDCl3): = 20.95.
2,2 ,2 ,2 -{[(1,1 -Biphenyl)-4,4 -diyl-(1E)-2,1-ethenediyl]di-
nitrilo}tetrakisethanol (10)
Anal. Calcd for C37H47INP (663.67): C, 66.96; H, 7.14; N, 2.11.
Found: C, 66.97; H, 7.14; N, 2.21.
To a solution of 7b (1.654 g, 2.2 mmol) and (1,1 -biphenyl)-4,4 -
dicarboxaldehyde (210 mg, 1 mmol) in anhyd CH2Cl2 (15 mL) was
added t-BuOK (370 mg, 3.3 mmol). The mixture was stirred at r.t.
for 5 h. After filtration through Celite, the solvent was evaporated.
The crude compound was isomerized in Et2O–CH2Cl2 (7:2; 9 mL),
with a catalytic amount of I2, at r.t. for 4 h under light exposure (75
W lamp). The organic layer was washed with aq Na2S2O3 and dried
(Na2SO4). The solvent was evaporated and the residue was purified
by column chromatography (CH2Cl2–EtoAC, gradient from 100:0
to 98:2) to yield 9.
{[4-(Dioctylamino)phenyl]methyl}triphenylphosphonium
Iodide (4)
Mp 147–149 °C.
1H NMR (CDCl3): = 7.79 and 7.66 (m, 15 H), 6.80 (dd, J = 8.6,
2.1, 2 H), 6.36 (d, J = 8.6, 2 H), 4.86 (d, J = 12.6, 2 H), 3.17 (t,
J = 7.4, 4 H), 1.49 (m, 4 H), 1.27 (m, 20 H), 0.88 (t, J = 6.4, 6 H).
13C NMR (CDCl3): = 146.6 (d, J = 2.3), 133.7, 133.0 (d, J = 9.9),
130.9 (d, J = 4.3), 128.9 (d, J = 12.4), 116.4 (d, J = 85.0), 110.2,
109.7 (d, J = 9.0), 49.5, 30.4, 29.0 (d, J = 45.3), 28.0, 27.9, 25.7,
21.3, 12.8.
Yield: 1.586 g (80%).
1H NMR (CDCl3): = 7.61 and 7.54 (AA XX , JAX = 8.7, 8 H), 7.41
and 6.75 (AA XX , JAX = 8.9, 8 H), 7.08 (d, J = 15.8, 2 H), 6.92 (d,
J = 16.2, 2 H), 4.61 (m, 4 H), 3.87 (m, 8 H), 3.70–3.47 (m, 16 H),
1.55 (m, 24 H).
31P NMR (121.50 MHz, CDCl3): = 21.04.
Anal. Calcd for C41H55INP (719.78): C, 68.42; H, 7.70; N, 1.94.
Found: C, 68.42; H, 7.71; N, 1.90.
HRMS: m/z calcd for C56H72N2O8 (M+·): 900.5289, found:
900.5289.
Triphenyl[(2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-9-
yl)methyl]phosphonium Iodide (5)
Mp 185–189 °C.
1H NMR (CDCl3): = 7.80 and 7.63 (m, 15 H), 6.25 (d, J = 2.6, 2
H), 4.65 (d, J = 12.6, 2 H), 3.09 (t, J = 5.5, 4 H), 2.44 (t, J = 6.2, 4
H), 1.83 (m, 4 H).
13C NMR (CDCl3): = 142.7, 135.0 (d, J = 2.9), 134.2 (d, J = 9.9),
130.0 (d, J = 12.3), 129.5 (d, J = 5.3), 121.6, 117.6 (d, J = 85.0),
110.3, 49.6, 31.0 (d, J = 46.4), 27.2, 21.4.
Product 9 was dissolved in EtOH–CH2Cl2 (3:7; 10 mL) and aq HCl
(10%; 1 mL) was added. After stirring for 90 h at r.t., the residue
was filtered and washed with H2O and EtOH to yield 10.
Yield: 517 mg (52%); mp >250 °C.
1H NMR (DMSO-d6): = 7.67 and 7.59 (AA XX , JAX = 8.2, 8 H),
7.41 and 6.70 (AA XX , JAX = 8.3, 8 H), 7.16 (d, J = 16.2, 2 H), 6.96
(d, J = 16.2, 2 H), 4.74 (m, 4 H), 3.55 (m, 8 H), 3.31 (m, 8 H).
31P NMR (CDCl3): = 20.60.
HRMS: m/z calcd for C31H31NP (M+·): 448.2194, found: 448.2193.
Acknowledgments
We acknowledge financial support from C.N.R.S. and M.E.N.R.T.
Synthesis 2003, No. 10, 1541–1544 © Thieme Stuttgart · New York